Level Biotechnology Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	736.59	731.35	660.61	593.01	677.28
Revenue Growth (YoY)	0.72%	10.71%	11.40%	-12.44%	0.71%
Cost of Revenue	478.9	494.22	441.07	390.42	444.78
Gross Profit	257.7	237.13	219.55	202.59	232.5
Selling, General & Admin	160.48	148.92	137.98	123.66	138.52
Research & Development	13.7	12.95	13.77	14.03	15.02
Operating Expenses	174.15	161.81	151.99	137.69	153.54
Operating Income	83.55	75.32	67.55	64.9	78.96
Interest Expense	-0.2	-0.28	-0.33	-0.35	-0.38
Interest & Investment Income	3.42	5.45	5.18	2.47	1.67
Currency Exchange Gain (Loss)	-	-1.2	0.01	-1.17	1.65
Other Non Operating Income (Expenses)	10.81	1.82	6.14	7.21	3.12
EBT Excluding Unusual Items	97.58	81.1	78.55	73.07	85.02
Gain (Loss) on Sale of Assets	-	0.02	0.1	0.08	-0.13
Pretax Income	97.58	81.13	78.65	73.16	84.89
Income Tax Expense	17.88	16.31	15.75	14.69	16.71
Net Income	79.7	64.81	62.91	58.47	68.18
Net Income to Common	79.7	64.81	62.91	58.47	68.18
Net Income Growth	22.97%	3.03%	7.59%	-14.25%	17.46%
Shares Outstanding (Basic)	32	32	32	32	32
Shares Outstanding (Diluted)	33	33	33	33	33
Shares Change (YoY)	0.04%	-0.02%	-0.04%	0.01%	0.19%
EPS (Basic)	2.46	2.00	1.94	1.80	2.10
EPS (Diluted)	2.44	1.99	1.93	1.79	2.09
EPS Growth	22.61%	3.11%	7.82%	-14.35%	17.42%
Free Cash Flow	26.94	-159.58	62.54	58.33	146.8
Free Cash Flow Per Share	0.82	-4.89	1.92	1.79	4.49
Dividend Per Share	-	1.800	1.700	1.700	1.900
Dividend Growth	-	5.88%	-	-10.53%	18.75%
Gross Margin	34.98%	32.42%	33.23%	34.16%	34.33%
Operating Margin	11.34%	10.30%	10.23%	10.95%	11.66%
Profit Margin	10.82%	8.86%	9.52%	9.86%	10.07%
Free Cash Flow Margin	3.66%	-21.82%	9.47%	9.84%	21.67%
EBITDA	106	91.02	83.21	80.73	95.15
EBITDA Margin	14.39%	12.45%	12.60%	13.61%	14.05%
D&A For EBITDA	22.46	15.7	15.65	15.82	16.19
EBIT	83.55	75.32	67.55	64.9	78.96
EBIT Margin	11.34%	10.30%	10.23%	10.95%	11.66%
Effective Tax Rate	18.32%	20.11%	20.02%	20.08%	19.69%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.